Quantabio

Quantabio is a private life science tools company that develops and commercializes DNA and RNA amplification reagents, sequencing workflow products, and qPCR instrumentation for research, translational, drug discovery, and public health laboratories. The company focuses on molecular biology workflows spanning sample preparation, reverse transcription, PCR, qPCR, and next-generation sequencing library preparation and quantification. Its portfolio includes reagent brands such as ToughMix, AccuStart, qScript, repliQa, Extracta, and sparQ, as well as the Q qPCR cycler. Quantabio emphasizes performance on difficult samples, inhibitor tolerance, room-temperature stability, and streamlined workflows for demanding molecular testing applications. Founded as Quanta BioSciences in 2001, the company was later renamed Quantabio and has operated as part of QIAGEN since its 2011 acquisition while continuing to market products under the Quantabio brand.